ライフサイエンスコーパス: bioterrorism

1 A select agent and thus a potential agent of bioterrorism.

2 enic and classified as a category A agent of bioterrorism.

3 th the potential for subversion as agents of bioterrorism.

4 threat to humans and is a potential agent of bioterrorism.

5 t is presently feared as a possible agent of bioterrorism.

6 spread of infectious diseases and potential bioterrorism.

7 orly immunogenic vaccines, and the threat of bioterrorism.

8 fever and is considered a potential agent of bioterrorism.

9 l in humans and could be used as an agent of bioterrorism.

10 infectiousness make it a potential agent of bioterrorism.

11 because of its potential use as an agent of bioterrorism.

12 for public safety amid the growing threat of bioterrorism.

13 s of an epidemic model, focusing on smallpox bioterrorism.

14 ay not be applicable to some threats such as bioterrorism.

15 ty, has increased exponentially in an age of bioterrorism.

16 reating infections caused by these agents of bioterrorism.

17 odel may be needed to address the threats of bioterrorism.

18 f the AIDS pandemic and the threat of global bioterrorism.

19 a) poses a significant threat as an agent of bioterrorism.

20 disease, and they pose a threat as agents of bioterrorism.

21 ion in indoor environments and the threat of bioterrorism.

22 cal diagnosis, and the current fight against bioterrorism.

23 ns that it might be exploited as a weapon of bioterrorism.

24 ularensis bacteria, a Tier 1 Select Agent of bioterrorism.

25 ermeasures to combat this potential agent of bioterrorism.

26 adequate plans for dealing with agricultural bioterrorism.

27 ghly infectious agents that may be agents of bioterrorism.

28 of protecting against such future threats of bioterrorism.

29 re one of the highest-risk threat agents for bioterrorism.

30 also well recognized as a potential agent of bioterrorism.

31 event the potentially devastating effects of bioterrorism.

32 and is considered an agent of biowarfare or bioterrorism.

33 spiratory symptoms, infectious diseases, and bioterrorism.

34 ue to its high infectivity and potential for bioterrorism.

35 e agent of anthrax and a potential weapon of bioterrorism.

36 d and be useful tools in our arsenal against bioterrorism.

37 otential for international spread and use in bioterrorism.

38 icity, superantigens are potential agents of bioterrorism.

39 e deadliest agents of biological warfare and bioterrorism.

40 to world security, and increases the risk of bioterrorism.

41 nited States experienced a deliberate act of bioterrorism.

42 sepsis and is a major concern as a weapon of bioterrorism.

43 e case of malignancy, pandemic infection, or bioterrorism.

44 category (category A) of potential agents of bioterrorism.

45 there is concern that MPXV could be used for bioterrorism.

46 nt of anthrax disease, is a proven weapon of bioterrorism.

47 lity, ricin is considered a likely agent for bioterrorism.

48 erotoxin B (SEB), a potential incapacitating bioterrorism agent and a major cause of food poisoning,

49 attention because of its potential use as a bioterrorism agent and inadvertent introduction into Nor

50 tructure of PNGM from the human pathogen and bioterrorism agent Bacillus anthracis.

51 C. burnetii is considered a potential bioterrorism agent because of its low infectious dose; r

52 MARV has been identified as a category A bioterrorism agent by the Centers for Disease Control an

53 idae and has been classified as a Category A bioterrorism agent by the United States Centers for Dise

54 Bacillus anthracis is a bioterrorism agent classified by the Centers for Disease

55 ons in ultrasensitive molecular diagnostics, bioterrorism agent detection, and real-time imaging and

56 It is considered a potential agro-bioterrorism agent for which limited countermeasures are

57 or Disease Control and Prevention Category A bioterrorism agent Francisella tularensis and prototype

58 isms to cause disease, making this potential bioterrorism agent one of the most infectious bacterial

59 Francisella tularensis is a potential bioterrorism agent that is highly infectious at very low

60 ccines and antibiotics against the potential bioterrorism agent Yersinia pestis.

61 of the intracellular pathogen and potential bioterrorism agent, Brucella suis, was determined.

62 c threat of VEEV, and its potential use as a bioterrorism agent, there are no FDA-approved antivirals

63 ly virulent zoonotic pathogen and category B bioterrorism agent, was sequenced by the random shotgun

64 to wide availability and potential use as a bioterrorism agent, with particular concern for food sup

65 t smallpox because of its potential use as a bioterrorism agent.

66 has recently been classified as a category A bioterrorism agent.

67 so recently received attention as a possible bioterrorism agent.

68 ar bacterium Coxiella burnetii, a category B bioterrorism agent.

69 rom the potential use of smallpox virus as a bioterrorism agent.

70 thracis can cause anthrax and is a potential bioterrorism agent.

71 most toxic protein known to man and a Tier 1 bioterrorism agent.

72 tularensis, which is recognized as a Tier 1 bioterrorism agent.

73 causative agent of anthrax, is a well known bioterrorism agent.

74 ed as a Tier 1 select agent and a category A bioterrorism agent.

75 e causative agent of anthrax, is a potential bioterrorism agent.

76 tein synthesis and is considered a potential bioterrorism agent.

77 frica, Asia, and the Americas and is a known bioterrorism agent.

78 en to assess water quality and as a possible bioterrorism agent.

79 s and is currently of concern as a potential bioterrorism agent.

80 ity, genetic homogeneity, and potential as a bioterrorism agent.

81 n, ricin has been classified as a category B bioterrorism agent.

82 ausative agent of tularemia, is a category A bioterrorism agent.

83 se concern because of its potential use as a bioterrorism agent.

84 ant cause of food poisoning and is a class B bioterrorism agent.

85 e causative agent of tularemia, a category A bioterrorism agent.

86 is an important human pathogen and potential bioterrorism agent.

87 de an attractive technology platform against bioterrorism agents due to their safety record in humans

88 Heightened fear of bioterrorism agents has caused health officials to re-ex

89 Furthermore, detection of bioterrorism agents in water, food and environmental sam

90 ct pathogenic bacteria, especially potential bioterrorism agents like Yersinia pestis and Bacillus an

91 er, multidrug-resistant strains of bacterial bioterrorism agents occur naturally or have been bio-eng

92 For example, the bioterrorism agents of greatest concern cause initial sy

93 umber of protein toxins, including potential bioterrorism agents such as ricin and botulinum neurotox

94 l pyrogenic exotoxins] and anthrax toxin are bioterrorism agents that cause diseases by immunostimula

95 has been developed for specific detection of bioterrorism agents, as exemplified by ricin, cholera to

96 ) Sterne, surrogates for potential bacterial bioterrorism agents, as well as selective measurements o

97 o emerging infectious diseases and potential bioterrorism agents.

98 consideration in designing therapeutics for bioterrorism agents.

99 the most potent toxins known, are potential bioterrorism agents.

100 the treatment of disease caused by potential bioterrorism agents.

101 (BoNT/A to BoNT/G) that are major potential bioterrorism agents.

102 fever with high mortality and are potential bioterrorism agents.

103 mallei and Burkholderia mallei are potential bioterrorism agents.

104 accines as well as their potential misuse as bioterrorism agents.

105 ns in humans and are high-priority potential bioterrorism agents.

106 s Review, we discuss the potential threat of bioterrorism, agents that could be exploited, and recent

107 e common infectious processes from agents of bioterrorism also could improve management strategies.

108 Bioterrorism and abortion were also important issues for

109 continues to generate concern as an agent of bioterrorism and as a natural cause of sporadic disease

110 ures make Ebola virus a potential weapon for bioterrorism and biological warfare.

111 so more recent issues such as food security, bioterrorism and climate change.

112 Concerns over bioterrorism and emerging diseases have led to the wides

113 ations of surveillance systems for detecting bioterrorism and emerging infections are insufficient to

114 e in vaccinating against potential agents of bioterrorism and emerging infections because of their pr

115 gnostics with major impacts in areas such as bioterrorism and food safety.

116 Concerns about bioterrorism and influenza have focused attention on ide

117 NBS-22 focuses primarily on bioterrorism and laboratory accidents, neglecting threat

118 ortality rate and a target of concern due to bioterrorism and long-term site contamination.

119 Thus, rapid methods to distinguish between bioterrorism and naturally occurring plague infections a

120 The unpredictable nature of bioterrorism and the absence of real-time detection syst

121 Given the threat of bioterrorism and the increasing availability of electron

122 use of the potential for use of the toxin in bioterrorism and the increasingly widespread application

123 alth threats both through the possibility of bioterrorism and the intentional release of smallpox and

124 Tube extracts from several agents of bioterrorism and their near neighbors were analyzed in a

125 From a bioterrorism and warfare perspective, these agents are l

126 s and are considered as potential agents for bioterrorism and warfare.

127 number of mechanisms, which include disease, bioterrorism, and destruction of both plant and animal f

128 cause major public concern for food safety, bioterrorism, and nosocomial infections.

129 Ricin is a category B agent for bioterrorism, and Shiga toxins are the primary virulence

130 , whether naturally occurring or a result of bioterrorism, and thus can be an integral component of a

131 ct against radiation toxicities from acts of bioterrorism, as well as cancer treatment.

132 de a model for the study of both natural and bioterrorism associated disease.

133 Prevention or therapy for bioterrorism-associated anthrax infections requires rapi

134 of intense study as a result of its use in a bioterrorism attack in the United States in September an

135 ients with inhalational anthrax related to a bioterrorism attack in the United States.

136 In 2001, a bioterrorism attack involving Bacillus anthracis spore-l

137 arth and represent a serious problem for (i) bioterrorism attack, (ii) horizontal transmission of mic

138 improved clinical outcomes in the event of a bioterrorism attack.

139 with the target organisms in the event of a bioterrorism attack.

140 tment and reduce mortality in the event of a bioterrorism attack.

141 ion and more rapid therapy in the event of a bioterrorism attack.

142 y data to detect a large-scale but localized bioterrorism attack.

143 The agents most likely to be used in bioterrorism attacks are reviewed, along with the clinic

144 an essential role in the pathogenesis of the bioterrorism bacterium Bacillus anthracis.

145 thods to the analysis of evidence related to bioterrorism, biocrimes, hoaxes, or the accidental relea

146 (from 1966 to 2004) for articles relating to bioterrorism, biological agents, biological warfare, hos

147 is, biological weapon, biological terrorism, bioterrorism, biological warfare, and biowarfare.

148 e-threatening infections during outbreaks or bioterrorism (BT) events and, in some cases, can experie

149 its classification as a category A agent of bioterrorism, but little is known about the molecular me

150 ularemia and a category A potential agent of bioterrorism, but the pathogenic mechanisms of F. tulare

151 y can become much better prepared to counter bioterrorism by developing a list of likely anti-crop th

152 ion in humans and animals and has been a top bioterrorism concern since the 2001 anthrax attacks in t

153 Bacillus anthracis remains a serious bioterrorism concern, and the currently licensed vaccine

154 ectious agents with pandemic potential or of bioterrorism concern.

155 f botulinum neurotoxin (BoNT) is a potential bioterrorism concern.

156 iruses are under intense research because of bioterrorism concerns, zoonotic infections, and the side

157 importance of dermatologist preparedness for bioterrorism, dermatologist knowledge regarding smallpox

158 Surveillance for bioterrorism detection, in particular, raises unique iss

159 surveillance systems, 20 systems collecting bioterrorism detector data, 13 systems collecting influe

160 We simulated outbreaks for these bioterrorism diseases and evaluated the performance of o

161 rriers to surge capacity in the setting of a bioterrorism event and to identify solutions to these pr

162 During the bioterrorism event of 2001, we applied two novel immunoh

163 and may impact public health management of a bioterrorism event.

164 role of pathology in investigating potential bioterrorism events and in guiding epidemiological studi

165 national capacities to detect and respond to bioterrorism events and naturally occurring outbreaks of

166 plague and the forensic analysis of possible bioterrorism events.

167 d it has been invoked in federally sponsored bioterrorism exercises.

168 cumented inhalational anthrax resulting from bioterrorism exposure are presented.

169 rensic science, embryonic disease diagnosis, bioterrorism genome detection, "immortalization" of clin

170 e agent of anthrax and a potential weapon of bioterrorism, grows rapidly in mammalian hosts, which su

171 As the potential for bioterrorism has appeared to increase, the need for simp

172 The possibility of bioterrorism has been met by significant financial outla

173 20 years ago, its potential release through bioterrorism has generated renewed interest in vaccinati

174 naturally occurring smallpox, the threat of bioterrorism has led to renewed vaccination programs.

175 lnesses and syndromes potentially related to bioterrorism have proliferated.

176 Threats of bioterrorism have renewed efforts to better understand p

177 surge capacities to deal with a significant bioterrorism incident.

178 e of renewed interest in potential agents of bioterrorism, including Y. pestis.

179 ng clinicians and laboratorians to potential bioterrorism-initiated outbreaks as well as look-alike d

180 in part to recently heightened concern over bioterrorism, interest in the mechanism of action of bot

181 Combating bioterrorism is a challenge to all of us.

182 n response to a select agent event or act of bioterrorism is reviewed.

183 ther through natural means or as a result of bioterrorism, is of significant concern.

184 trategies would provide a better response to bioterrorism, mass vaccination, or vaccination of social

185 o get ready, and in the process be ready for bioterrorism, natural disasters, and epidemics of other

186 h the powers they need to detect and contain bioterrorism or a naturally occurring disease outbreak.

187 is may be deliberately released in an act of bioterrorism or war.

188 bioaerosol is of the greatest concern from a bioterrorism or warfare perspective, potentially capable

189 tion exposure as part of a nuclear accident, bioterrorism, or a nuclear attack.

190 (SEB) may occur accidentally, as a result of bioterrorism, or during colonization or infection of the

191 gnized as potential agents of biowarfare and bioterrorism owing to their morbidity and mortality in h

192 s, and their potential use as instruments of bioterrorism, pose a significant threat to the developed

193 Bioterrorism poses a daunting challenge to global securi

194 Bioterrorism poses a major threat to public health, as t

195 ct Terrorism" (USA PATRIOT) Act and the 2002 Bioterrorism Preparedness Act on US select agent researc

196 em data were designed, at least in part, for bioterrorism preparedness applications.

197 ts) demanded in the medical, veterinary, and bioterrorism prevention arenas.

198 spans from human and veterinary medicine to bioterrorism prevention.

199 Despite having a laboratory bioterrorism procedure in place and adhering to establis

200 Bioterrorism provides a powerful metaphor for elite fear

201 to immune plasma and an effective dual use (bioterrorism/public health) therapeutic.

202 cult to differentiate from illness caused by bioterrorism, rapidly spreading infection, or toxic subs

203 d poor life adjustment 1 year after onset of bioterrorism-related anthrax disease.

204 Bioterrorism-related anthrax exposures occurred at the U

205 d 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with com

206 about potential long-term health effects of bioterrorism-related Bacillus anthracis infection.

207 cell responses were studied in patients with bioterrorism-related cutaneous or inhalation anthrax and

208 ical and IHC studies of patients who died of bioterrorism-related inhalational anthrax confirmed the

209 We describe the 11th case of bioterrorism-related inhalational anthrax reported in th

210 During the recent bioterrorism-related outbreaks, inhalational anthrax had

211 in public health and related fields such as bioterrorism response and preparedness.

212 plague worldwide and is considered a tier 1 bioterrorism select agent due to its potential for inten

213 ed in 1951 to be a defense against potential bioterrorism, serve the immediate needs for field invest

214 environmental relatives of select agents of bioterrorism significance.

215 rns about the use of smallpox as a weapon of bioterrorism since the world events in recent years.

216 se research expands to counter the threat of bioterrorism, so does suspicion and the need for guidanc

217 deployed for both event-based and continuous bioterrorism surveillance.

218 to-person transmission, and potential use in bioterrorism, the development of a vaccine against ebola

219 eat of the reemergence of smallpox following bioterrorism, the diversification and availability of po

220 ry syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and

221 in and other fast-acting toxins as agents of bioterrorism, there is an urgent need for the developmen

222 It is also listed as a category B bioterrorism threat agent by the U.S. Centers for Diseas

223 usative agent for anthrax, poses a potential bioterrorism threat and is capable of causing mass morbi

224 Bacillus anthracis, a bioterrorism threat as well as an agricultural concern,

225 ing clinical specimens, field samples during bioterrorism threat assessment, and samples from outbrea

226 ation of Yersinia pestis, represents a major bioterrorism threat for which no vaccine is available.

227 its ease of production have made it a major bioterrorism threat worldwide.

228 Smallpox constitutes a major bioterrorism threat, which underscores the need to devel

229 The toxin is also a bioterrorism threat, yet no pharmacological antagonist t

230 l disease that has re-emerged as a potential bioterrorism threat.

231 ve agent, Bacillus anthracis, poses a global bioterrorism threat.

232 orrhagic fever in humans and pose a credible bioterrorism threat.

233 gic fever in humans and also pose a credible bioterrorism threat.

234 n, and gastroenteritis and poses a potential bioterrorism threat.

235 rograms for this important public health and bioterrorism threat.

236 , DNA vaccines against emerging pathogens or bioterrorism threats can be quickly constructed based so

237 In response to bioterrorism threats, anthrax vaccine has been used by t

238 d activity, combined with today's climate of bioterrorism threats, has heightened the need for high-t

239 inue to be delivered in response to possible bioterrorism threats.

240 lness after inhalation make some rickettsiae bioterrorism threats.

241 Bioterrorism using anthrax claimed five lives in the Uni

242 Only a few years ago bioterrorism was considered a remote concern but few tod

243 Until 1997, the subject of bioterrorism was not discussed within the medical commun

244 With the threat of smallpox virus as a bioterrorism weapon, questions have been asked about the

245 that occurs in the tropics, and a potential bioterrorism weapon.

246 ncern that smallpox viruses could be used as bioterrorism weapons.

247 lla tularensis (Ft) is a potential weapon of bioterrorism when aerosolized.

248 Possible bioterrorism with smallpox has led to the resumption of

249 The concern about bioterrorism with smallpox has raised the possibility of

250 In response to possible bioterrorism with smallpox, the UK government vaccinated